New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis

New evaluation of the tumor immune microenvironment of non-small cell lung cancer and its association with prognosis

BACKGROUND: A better understanding of the tumor immune microenvironment (TIME) will facilitate the development of prognostic biomarkers and more effective therapeutic strategies in patients with lung cancer. However, little has been reported on the comprehensive evaluation of complex interactions am...

Full description

Bibliographic Details
Main Authors: Adachi, K. (Author), Demachi-Okamura, A. (Author), Fujinaga, K. (Author), Hatooka, S. (Author), Kaneda, S. (Author), Komuro, H. (Author), Kuroda, H. (Author), Masago, K. (Author), Matsui, T. (Author), Matsushita, H. (Author), Miyai, M. (Author), Muraoka, D. (Author), Nakada, T. (Author), Nishida, R. (Author), Ohtsuka, T. (Author), Sakakura, N. (Author), Sasano, H. (Author), Shigematsu, Y. (Author), Shinohara, S. (Author), Shomura, S. (Author), Sugita, Y. (Author), Takahara, H. (Author), Takahashi, Y. (Author), Takao, M. (Author), Watanabe, F. (Author), Yamaguchi, R. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Antigens, Neoplasm
Carcinoma, Non-Small-Cell Lung
genetics
human
Humans
Immunologic Surveillance
Lung Neoplasms
lung tumor
non small cell lung cancer
phosphatidylinositol 3 kinase
Phosphatidylinositol 3-Kinases
prognosis
Prognosis
tumor microenvironment
Tumor Microenvironment
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items